Dr Wade Mueller, MD | |
9200 W Wisconsin Ave, Department Of Neurosurgery, Milwaukee, WI 53226-3522 | |
(414) 805-5400 | |
(414) 805-2084 |
Full Name | Dr Wade Mueller |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 41 Years |
Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356393094 | NPI | - | NPPES |
1356393094 | Medicaid | WI | |
002000126W | Other | HUMANA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 26007 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Medical College Of Wisconsin Inc | 2668384371 | 1813 |
News Archive
Patients with double hit lymphoma (DHL) who undergo autologous stem-cell transplantation (autoSCT) after achieving remission are not more likely to remain in remission or live longer than patients who do not undergo autoSCT, according to a new analysis from the Perelman School of Medicine and the Abramson Cancer Center of the University of Pennsylvania.
Cogdell Spencer Inc. announced today the tax characteristics of its 2009 dividends. We are releasing this information to assist those required to distribute Form 1099s on the Company's dividend. This release is based on an estimate of "earnings and profits" as defined by the Internal Revenue Service. No material change in these classifications is expected.
Navigating the Challenges of Meaningful Use to Identify Benefits, March 31, 2010, 2 p.m. CT, a Webinar hosted by Informatics Corporation of America, will explore how to practically implement a community-wide solution that assists its healthcare participants to achieve the proposed American Recovery and Reinvestment Act's criteria for meaningful use and bridge gaps in the adoption of electronic health records by its provider community.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of aldoxorubicin for the treatment of Kaposi's Sarcoma (KS) in HIV-infected patients.
Medasys Inc., a medical device company focused on providing implantable drug delivery solutions, announced today that it has received PMA approval from the U. S. Food and Drug Administration for its Prometra programmable implantable drug pump.
› Verified 3 days ago
Entity Name | The Medical College Of Wisconsin Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Patients with double hit lymphoma (DHL) who undergo autologous stem-cell transplantation (autoSCT) after achieving remission are not more likely to remain in remission or live longer than patients who do not undergo autoSCT, according to a new analysis from the Perelman School of Medicine and the Abramson Cancer Center of the University of Pennsylvania.
Cogdell Spencer Inc. announced today the tax characteristics of its 2009 dividends. We are releasing this information to assist those required to distribute Form 1099s on the Company's dividend. This release is based on an estimate of "earnings and profits" as defined by the Internal Revenue Service. No material change in these classifications is expected.
Navigating the Challenges of Meaningful Use to Identify Benefits, March 31, 2010, 2 p.m. CT, a Webinar hosted by Informatics Corporation of America, will explore how to practically implement a community-wide solution that assists its healthcare participants to achieve the proposed American Recovery and Reinvestment Act's criteria for meaningful use and bridge gaps in the adoption of electronic health records by its provider community.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of aldoxorubicin for the treatment of Kaposi's Sarcoma (KS) in HIV-infected patients.
Medasys Inc., a medical device company focused on providing implantable drug delivery solutions, announced today that it has received PMA approval from the U. S. Food and Drug Administration for its Prometra programmable implantable drug pump.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Wade Mueller, MD 9200 W Wisconsin Ave, Department Of Neurosurgery, Milwaukee, WI 53226-3522 Ph: (414) 805-5400 | Dr Wade Mueller, MD 9200 W Wisconsin Ave, Department Of Neurosurgery, Milwaukee, WI 53226-3522 Ph: (414) 805-5400 |
News Archive
Patients with double hit lymphoma (DHL) who undergo autologous stem-cell transplantation (autoSCT) after achieving remission are not more likely to remain in remission or live longer than patients who do not undergo autoSCT, according to a new analysis from the Perelman School of Medicine and the Abramson Cancer Center of the University of Pennsylvania.
Cogdell Spencer Inc. announced today the tax characteristics of its 2009 dividends. We are releasing this information to assist those required to distribute Form 1099s on the Company's dividend. This release is based on an estimate of "earnings and profits" as defined by the Internal Revenue Service. No material change in these classifications is expected.
Navigating the Challenges of Meaningful Use to Identify Benefits, March 31, 2010, 2 p.m. CT, a Webinar hosted by Informatics Corporation of America, will explore how to practically implement a community-wide solution that assists its healthcare participants to achieve the proposed American Recovery and Reinvestment Act's criteria for meaningful use and bridge gaps in the adoption of electronic health records by its provider community.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of aldoxorubicin for the treatment of Kaposi's Sarcoma (KS) in HIV-infected patients.
Medasys Inc., a medical device company focused on providing implantable drug delivery solutions, announced today that it has received PMA approval from the U. S. Food and Drug Administration for its Prometra programmable implantable drug pump.
› Verified 3 days ago
Dr. Christopher E Wolfla, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Spine Care Clinic At Plank Road, Milwaukee, WI 53226 Phone: 414-805-9255 Fax: 414-955-0110 | |
Mr. Cully R White, DO Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2901 W Kinnickinnic River Parkway, Suite 201, Milwaukee, WI 53215 Phone: 414-649-3232 Fax: 414-385-1929 | |
Dr. Sean M Lew, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-266-6435 Fax: 414-955-0131 | |
Dr. Shekar N Kurpad, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Spine Care Clinic At Plank Road, Milwaukee, WI 53226 Phone: 414-955-7188 Fax: 414-955-0110 | |
Huy Q Truong, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-5400 Fax: 414-955-0115 | |
Dr. Andrew V Beykovsky, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2301 N Lake Dr, Milwaukee, WI 53211 Phone: 142-987-1424 | |
Saman Shabani, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8710 Fax: 414-805-1101 |